Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Silicon containing doai
Patent
1997-08-29
2000-11-21
Berch, Mark L
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Silicon containing doai
546 14, 558302, 560 30, C07F 708, A61P 3500, A61K 31695
Patent
active
061503436
ABSTRACT:
The present invention provides generally a compound having the following general formula (1): ##STR1## wherein R.sup.1 and R.sup.2 are independently the same or different and are hydrogen, an alkyl group, an alkenyl group, a benzyl group, an alkynyl group, an alkoxyl group, an aryloxy group, an acyloxy group, a OC(O)OR.sup.d group, a carbamoyloxy group, a halogen, a hydroxyl group, a nitro group, a cyano group, an azido group, a formyl group, a hydrazino group, an acyl group, an amino group, --SR.sup.c, wherein, R.sup.c is hydrogen, an acyl group, an alkyl group, or an aryl group, or R.sup.1 and R.sup.2 together form a group of the formula --O(CH.sub.2).sub.n O-- wherein n represents the integer 1 or 2; R.sup.3 is H, F, a halogen atom, a nitro group, an amino group, a hydroxyl group, or a cyano id group; or R.sup.2 and R.sup.3 together form a group of the formula --O(CH.sub.2).sub.n O-- wherein n represents the integer 1 or 2; R.sup.4 is H, F, a C.sub.1-3 alkyl group, a C.sub.2-3 alkenyl group, a C.sub.2-3 alkynyl group, or a C.sub.1-3 alkoxyl group; R.sup.5 is a C.sub.1-10 alkyl group, or a propargyl group; and R.sup.6, R.sup.7 and R.sup.8 are independently a C.sub.1-10 alkyl group, a C.sub.2-l0 alkenyl group, a C.sub.2-10 alkynyl group, an aryl group or a --(CH.sub.2).sub.N R.sup.9 group, wherein N is an integer within the range of 1 through 10 and R.sup.9 is a hydroxyl group, alkoxy group, an amino group, an alkylamino group, a dialkylamino group, a halogen atom, a cyano group or a nitro group; and pharmaceutically acceptable salts thereof.
REFERENCES:
patent: 5468859 (1995-11-01), Fortunak
patent: 5700939 (1997-12-01), Fortunak
patent: 5910491 (1999-06-01), Hausheer
Curran, D.P. and Liu, H., "New 4+1 Radical Annulations--A Formal Total Synthesis of (+/-)-Camptothecin," J. Am. Chem Soc., 114, 5863-5864 (1992). Published Jul. 1, 1992.
Curran, D.P., "The Camptothecins--A reborn Family of Antitumor Agents", J. Chin. Chem. Soc., 40, 1-6 1(993). Published Feb. 1993.
Curran, D.P. et al., "Recent Applications of Radical Reactions in Natural Product Synthesis," Pure Appl. Chem., 65, 1153-1159 (1993). Published Jun. 1993.
Curran, D.P. et al., "Cascade Radical Reactions of Isonitriles: A Second-Generation Synthesis of (20S)-Camptothecin, Topotecan, Irinotecan, and GI-147211C," Angew. Chem. Int. Ed, 34, 2683-2684 (1995). Published Jan. 15, 1996.
Curran, D.P., Liu, H.; Josien, H; Ko, S.B., "Tandem Radical Reactions of Isonitriles with 2-pyrdonyl and other aryl radicals: Scope and Limitations, and a First Generation Sunthesis of (+/-)-Camptothecin," Tetrahedron, 52, 11385-11404 (1996). Published Aug. 1996.
Josien, H. and Curran, D.P., "Synthesis of (S)-mappicine and Mappicine Ketone Via Radical Cascade Reaction of IsonitilLes," Tetrahedron, 53, 8881-8886 (1997). Published Jun. 30, 1997.
Liu, H. et al., "Selective N-Fnctionalization of 6-Substituted-2-Pyridones," Tetrahedron Letters, 36:49, 8917-8920 (1995).
Curran Dennis P.
David Bom
Josien Hubert
Berch Mark L
University of Pittsburgh
LandOfFree
Camptothecin analogs and methods of preparation thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Camptothecin analogs and methods of preparation thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Camptothecin analogs and methods of preparation thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1257275